Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Other Non-Current Liabilities: 2014

Historic Other Non-Current Liabilities for KalVista Pharmaceuticals (KALV) over the last 1 years, with Dec 2014 value amounting to $1.5 million.

  • KalVista Pharmaceuticals' Other Non-Current Liabilities was N/A to $99.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $99.9 million, marking a year-over-year change of. This contributed to the annual value of $1.5 million for FY2014, which is N/A change from last year.
  • Latest data reveals that KalVista Pharmaceuticals reported Other Non-Current Liabilities of $1.5 million as of FY2014.
  • Over the past 5 years, KalVista Pharmaceuticals' Other Non-Current Liabilities peaked at $1.5 million during FY2014, and registered a low of $1.5 million during FY2014.
  • Its 1-year average for Other Non-Current Liabilities is $1.5 million, with a median of $1.5 million in 2014.